IL-17C inhibits the development of hepatocellular carcinoma through the modulation of gut microbiota
作者
Huanle Gong,Shoubao Ma,Chen Dong,Haiyan Liu
出处
期刊:Journal of Immunology [American Association of Immunologists] 日期:2018-05-01卷期号:200 (Supplement_1): 124.1-124.1
标识
DOI:10.4049/jimmunol.200.supp.124.1
摘要
Abstract IL-17C has been recently reported to play an important role in infections and inflammatory diseases. However, its function in anti-tumor immune response is not clear. Here, we investigated the role of IL-17C in murine hepatocellular carcinoma (HCC) models and found that genetic depletion of IL-17C significantly promoted HCC growth, whilst overexpression of IL-17C inhibited HCC development. Flow cytometry analysis further demonstrated that the percentage of CD8+ T cells was reduced in IL-17C−/− mice. Moreover, the activation of T cells was also significantly reduced when IL-17C was deficient. Interestingly, depletion of gut microbiota with antibiotics treatment diminished the difference in tumor burdens between WT and IL-17C−/− groups, indicating microbiota might be involved in the process of IL-17C regulating HCC development. In addition, 16sRNA sequencing results revealed that IL-17C deficiency significantly reduced the Lactobacillus acidophilus colonization. Collectively, we found that IL-17C suppressed HCC growth in a gut microbiota-dependent manner. Further studies are needed to confirm the contribution of L.acidophilus to HCC development and investigate the detailed mechanisms of IL-17C regulating anti-tumor immune response.